Suri Rita S, Mahon Jeffrey L, Clark William F, Moist Louise M, Salvadori Marina, Garg Amit X
1Division of Nephrology, Department of Medicine, University of Western Ontario, London, Ontario, Canada.
Kidney Int Suppl. 2009 Feb(112):S44-6. doi: 10.1038/ki.2008.619.
Ingestion of Escherichia coli O157:H7 can cause a spectrum of acute illness, ranging from overt hemolytic-uremic syndrome (HUS), to gastroenteritis with bloody diarrhea, to no symptoms. This organism has been responsible for dozens of outbreaks of gastroenteritis and HUS in industrialized nations, and thus is a major public health concern. Although the acute effects of E. coli O157:H7 ingestion are well understood, the long-term complications are less well known. Here, we review the biological and empirical evidence supporting a link between E. coli O157:H7 and long-term diabetes mellitus. Survivors with diarrhea-associated HUS have a significantly increased incidence of diabetes due to complete insulin deficiency, which may recur several years after the initial infection. However, less severe forms of infection, such as E. coli O157:H7 gastroenteritis without overt HUS, do not appear to result in an increased risk of type 2 diabetes.
摄入大肠杆菌O157:H7可引发一系列急性疾病,从明显的溶血尿毒综合征(HUS)到伴有血性腹泻的肠胃炎,再到无症状。这种细菌已在工业化国家引发了数十起肠胃炎和HUS疫情,因此是一个重大的公共卫生问题。尽管摄入大肠杆菌O157:H7的急性影响已为人熟知,但其长期并发症却鲜为人知。在此,我们综述支持大肠杆菌O157:H7与长期糖尿病之间存在关联的生物学和实证证据。腹泻相关性HUS的幸存者由于完全胰岛素缺乏,糖尿病发病率显著增加,这可能在初次感染数年之后复发。然而,感染程度较轻的形式,如无明显HUS的大肠杆菌O157:H7肠胃炎,似乎不会导致2型糖尿病风险增加。